Table 1.
Main patient characteristics
| Characteristic | No. of patients | % |
|---|---|---|
|
Patients evaluable |
41 |
100 |
|
Age, years |
|
|
| Median |
60 |
/ |
| Range |
32-75 |
|
|
ECOG PS |
|
|
| 0 |
13 |
32 |
| 1 |
21 |
51 |
| 2 |
7 |
17 |
|
Tumor histology/citology |
|
|
| Serous adenocarcinoma |
10 |
24.5 |
| Adenocarcinoma |
7 |
17 |
| Papillary serous |
6 |
15 |
| Clear cell adenocarcinoma |
2 |
5 |
| Endometrioid |
3 |
7 |
| Mucinous adenocarcinoma |
3 |
7 |
| Poorly differentiated |
10 |
24.5 |
|
Stage at diagnosis |
|
|
| I,II |
2 |
5 |
| III (A, B, C) |
33 (10, 12, 11) |
80 |
| IV |
6 |
15 |
|
N of prior chemotherapy regimens |
|
|
| 1 |
3 |
7 |
| 2 |
12 |
29 |
| ≥3 |
26 |
64 |
|
N of prior platinum-based regimens |
|
|
| 1 |
23 |
56 |
| 2 |
9 |
22 |
| 3 | 9 | 22 |
Abbreviations: ECOG PS, Eastern Cooperative Oncoloy Group Performance Status.